Class information for:
Level 1: IRF5//GENOM INVEST ONCOL GENYO//INTERFERON REGULATORY FACTOR 5

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
10461 1061 50.7 93%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
396 3       SYSTEMIC LUPUS ERYTHEMATOSUS//ANTIPHOSPHOLIPID SYNDROME//LUPUS 30351
302 2             SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS 18563
10461 1                   IRF5//GENOM INVEST ONCOL GENYO//INTERFERON REGULATORY FACTOR 5 1061

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IRF5 authKW 330927 2% 50% 23
2 GENOM INVEST ONCOL GENYO address 258998 1% 75% 12
3 INTERFERON REGULATORY FACTOR 5 authKW 245559 2% 53% 16
4 MARY KIRKLAND LUPUS address 227398 2% 44% 18
5 ARTHRIT CLIN IMMUNOL PROGRAM address 177006 3% 19% 33
6 GWEN KN P LUPUS IMMUNOL address 160235 3% 19% 29
7 SYSTEMIC LUPUS ERYTHEMATOSUS authKW 136760 20% 2% 213
8 ROSALIND RUSSELL MED ARTHRIT address 134252 3% 17% 28
9 CLIN IMMUNOL PROGRAM address 131551 1% 57% 8
10 BANK1 authKW 129499 1% 75% 6

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Rheumatology 49610 39% 0% 416
2 Immunology 5014 34% 0% 356
3 Genetics & Heredity 1137 15% 0% 156
4 Medicine, Research & Experimental 154 6% 0% 60
5 Cell Biology 117 7% 0% 79
6 Biochemistry & Molecular Biology 39 10% 0% 106
7 Medicine, General & Internal 23 4% 0% 42
8 Medical Laboratory Technology 13 1% 0% 9
9 Dermatology 3 1% 0% 10
10 Urology & Nephrology 2 1% 0% 13

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GENOM INVEST ONCOL GENYO 258998 1% 75% 12
2 MARY KIRKLAND LUPUS 227398 2% 44% 18
3 ARTHRIT CLIN IMMUNOL PROGRAM 177006 3% 19% 33
4 GWEN KN P LUPUS IMMUNOL 160235 3% 19% 29
5 ROSALIND RUSSELL MED ARTHRIT 134252 3% 17% 28
6 CLIN IMMUNOL PROGRAM 131551 1% 57% 8
7 IMMUNOL BIOMARKERS GRP 129499 1% 75% 6
8 BIOMED PARASITOL LOPEZ NEYRA 119908 0% 83% 5
9 SHANGHAI RHEUMATOL 112314 1% 35% 11
10 LUPUS GENET GRP 89928 0% 63% 5

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GENES AND IMMUNITY 38006 4% 3% 43
2 ARTHRITIS RESEARCH & THERAPY 36099 6% 2% 64
3 ARTHRITIS AND RHEUMATISM 21688 8% 1% 88
4 ARTHRITIS & RHEUMATOLOGY 12637 2% 2% 21
5 LUPUS 11642 4% 1% 39
6 ANNALS OF THE RHEUMATIC DISEASES 9047 5% 1% 53
7 CURRENT OPINION IN RHEUMATOLOGY 6770 2% 1% 19
8 NATURE REVIEWS RHEUMATOLOGY 5547 1% 2% 10
9 CLINICAL IMMUNOLOGY 3086 2% 1% 17
10 AUTOIMMUNITY 2307 1% 1% 13

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 IRF5 330927 2% 50% 23 Search IRF5 Search IRF5
2 INTERFERON REGULATORY FACTOR 5 245559 2% 53% 16 Search INTERFERON+REGULATORY+FACTOR+5 Search INTERFERON+REGULATORY+FACTOR+5
3 SYSTEMIC LUPUS ERYTHEMATOSUS 136760 20% 2% 213 Search SYSTEMIC+LUPUS+ERYTHEMATOSUS Search SYSTEMIC+LUPUS+ERYTHEMATOSUS
4 BANK1 129499 1% 75% 6 Search BANK1 Search BANK1
5 IRF 5 128189 1% 64% 7 Search IRF+5 Search IRF+5
6 INTERFERON SIGNATURE 115105 1% 50% 8 Search INTERFERON+SIGNATURE Search INTERFERON+SIGNATURE
7 FAM167A BLK 92089 0% 80% 4 Search FAM167A+BLK Search FAM167A+BLK
8 ITGAM 65400 0% 45% 5 Search ITGAM Search ITGAM
9 ANCESTRAL BACKGROUND 57556 0% 100% 2 Search ANCESTRAL+BACKGROUND Search ANCESTRAL+BACKGROUND
10 PHOX HOMOLOGY DOMAIN CONTAINING SERINE THREONINE KINASE 57556 0% 100% 2 Search PHOX+HOMOLOGY+DOMAIN+CONTAINING+SERINE+THREONINE+KINASE Search PHOX+HOMOLOGY+DOMAIN+CONTAINING+SERINE+THREONINE+KINASE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 CHAM, CM , KO, K , NIEWOLD, TB , (2012) INTERFERON REGULATORY FACTOR 5 IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - 66 81% 10
2 MOHAN, C , PUTTERMAN, C , (2015) GENETICS AND PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS.NATURE REVIEWS NEPHROLOGY. VOL. 11. ISSUE 6. P. 329 -341 75 38% 26
3 JAMES, JA , (2014) CLINICAL PERSPECTIVES ON LUPUS GENETICS ADVANCES AND OPPORTUNITIES.RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 40. ISSUE 3. P. 413 -+ 72 50% 2
4 LAZZARI, E , JEFFERIES, CA , (2014) IRF5-MEDIATED SIGNALING AND IMPLICATIONS FOR SLE.CLINICAL IMMUNOLOGY. VOL. 153. ISSUE 2. P. 343 -352 52 65% 9
5 KIROU, KA , GKROUZMAN, E , (2013) ANTI-INTERFERON ALPHA TREATMENT IN SLE.CLINICAL IMMUNOLOGY. VOL. 148. ISSUE 3. P. 303-312 46 65% 42
6 MATHIAN, A , HIE, M , COHEN-AUBART, F , AMOURA, Z , (2015) TARGETING INTERFERONS IN SYSTEMIC LUPUS ERYTHEMATOSUS: CURRENT AND FUTURE PROSPECTS.DRUGS. VOL. 75. ISSUE 8. P. 835 -846 51 56% 13
7 TERUEL, M , ALARCON-RIQUELME, ME , (2016) THE GENETIC BASIS OF SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT ARE THE RISK FACTORS AND WHAT HAVE WE LEARNED.JOURNAL OF AUTOIMMUNITY. VOL. 74. ISSUE . P. 161 -175 71 44% 1
8 LICHTMAN, EI , HELFGOTT, SM , KRIEGEL, MA , (2012) EMERGING THERAPIES FOR SYSTEMIC LUPUS ERYTHEMATOSUS - FOCUS ON TARGETING INTERFERON-ALPHA.CLINICAL IMMUNOLOGY. VOL. 143. ISSUE 3. P. 210 -221 60 53% 38
9 RULLO, OJ , TSAO, BP , (2013) RECENT INSIGHTS INTO THE GENETIC BASIS OF SYSTEMIC LUPUS ERYTHEMATOSUS.ANNALS OF THE RHEUMATIC DISEASES. VOL. 72. ISSUE . P. 56-61 46 60% 46
10 KO, K , KOLDOBSKAYA, Y , ROSENZWEIG, E , NIEWOLD, TB , (2013) ACTIVATION OF THE INTERFERON PATNWAY IS DEPENDENT UPON AUTOANTIBODIES IN AFRICAN-AMERICAN SLE PATIENTS, BUT NOT IN EUROPEAN-AMERICAN SLE PATIENTS.FRONTIERS IN IMMUNOLOGY. VOL. 4. ISSUE . P. - 37 84% 9

Classes with closest relation at Level 1


Rank Class id link
1 23444 MOL IMMUNOGENET GRP//CYTOGENET MUTAGENESIS//RUDBECK S
2 15666 PTPN22//PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22//PTPN22 GENE
3 16241 CELLULAR INJURY//TOLERANCE BREAKDOWN//HUNAN MED EPIGEN
4 17144 SYSTEMIC LUPUS ERYTHEMATOSUS//HLA DP T CELLS//IL 10 592A C
5 12735 PLASMACYTOID DENDRITIC CELLS//BDCA 4//PDC
6 25600 IFI16//HIN 200//P202
7 19765 A20//RNF11//ZINC FINGER PROTEIN A20
8 4753 TOLL LIKE RECEPTORS//TLR7//TOLL LIKE RECEPTOR 7
9 26623 PRISTANE//PLASMACYTOMAGENESIS//ABL MYC
10 12644 IRF 1//IRF 2//INTERFERON REGULATORY FACTOR

Go to start page